FDA articles including, memorandum, guidelines, process  
  SEARCH: Sign In | Register | Contact Us | Site Map | Home  

Resources for Food and Drug Administration (FDA)

Resources > FDA > Articles

Sub-Categories:

Listings 131 - 140 of 1028:

Consumers tune out FDA warnings
A flood of drug safety warnings from the Food and Drug Administration may have physicians and patients suffocating from information saturation. Expert...
Cooperative Arrangement between the Food and Drug Administration between USA and Australia
"The Food and Drug Administration, Department of Health and Human Services (FDA) of the United States of America and the Therapeutic Goods Administrat...
Counting FDA Approvals For Fun And Profit
Counting the number of new drugs trickling out of the Food and Drug Administration is an important measure of the health of the pharmaceutical industr...
Critics question FDA, U.S. Customs handling of Ranbaxy case
For two and a half years, the Food and Drug Administration collected evidence that Ranbaxy Laboratories, India's largest generic drugmaker, may have l...
CSPI Calls On FDA To Ban Eight Food Dyes
The Center for Science in the Public Interest (CSPI) yesterday called on the U.S. FDA to ban eight food dyes, used in products including General Mills...
CSPI Urges FDA to Facilitate Adverse Reaction Reporting for Dietary Supplements
The Food and Drug Administration (FDA) is under pressure from the dietary supplement industry to weakly implement a law intended to prevent a repeat o...
CT scan alert for pacemakers
The Food and Drug Administration is warning doctors and patients that electronic devices such as pacemakers, cardiac defibrillators and insulin pumps ...
CV Therapeutics: FDA to Review Ranexa
Biopharmaceutical company CV Therapeutics Inc. said Monday federal regulators will review its chest pain drug Ranexa as an initial treatment for angin...
Dangerous drug, do-nothing FDA
Research has shown that Darvocet (and its first cousin Darvon) is no more effective than acetaminophen (Tylenol) or aspirin, and perhaps it is no more...
Data shows Glaxo drug similar to placebo-US FDA
Company data for GlaxoSmithKline (nyse: GSK - news - people ) Plc's Promacta shows the experimental platelet-boosting drug works about as well as ...


Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 Next

  Search this category:




Google
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home
Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved.